Time-dependent changes of inflammatory mediators in the lungs of humans exposed to 0.4 ppm ozone for 2 hr: A comparison of mediators found in bronchoalveolar lavage fluid 1 and 18 hr after exposure

Toxicology and Applied Pharmacology

Volumn 138, Issue 1, 1996, Pages 176-185

  Devlin, Robert B ^a   McDonnell, William F ^a   Becker, Susanne ^a,c   Madden, Michael C ^a,b   McGee, Maria P ^d   Perez, Rafael ^b   Hatch, Gary ^a   House, Dennis E ^a   Koren, Hillel S ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c TRC Environmental   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDA ALBICANS;

BLOOD CLOTTING FACTOR 7; COMPLEMENT COMPONENT C3A; FIBRONECTIN; LACTATE DEHYDROGENASE; OZONE; PROSTAGLANDIN E2; THROMBOPLASTIN; THROMBOXANE B2; TRYPSIN INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INFLAMMATION; LUNG INJURY; LUNG LAVAGE; LUNG TOXICITY; MALE; NEUTROPHIL; NORMAL HUMAN;

ADOLESCENT; ADULT; ALPHA 1-ANTITRYPSIN; BLOOD COAGULATION FACTORS; BRONCHOALVEOLAR LAVAGE FLUID; CELL SURVIVAL; EICOSANOIDS; FIBRONECTINS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKINS; L-LACTATE DEHYDROGENASE; LEUKOCYTE COUNT; LUNG; MACROPHAGES, ALVEOLAR; MALE; OZONE; PHAGOCYTOSIS; PROTEINS; TIME FACTORS;

EID: 0029940437     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0111     Document Type: Article

References (37)

1. Bassett, D. J., Bowen-Kelly, E., Brewster, E. L., Elbon, C. L., Reichenbaugh, S. S., Bunton, T., and Kerr, J. S. (1988). A reversible model of acute lung injury based on ozone exposure. Lung 166, 355-369.
2. Bitterman, P. B., Rennard, S. I., Adelberg, S., and Crystal, R. G. (1983). Role of fibronectin as a growth factor for fibroblasts. J. Cell Biol. 97, 1925-1932.
3. Bhalla, D. K., and Young, C. (1992). Effects of acute exposure to ozone on rats: Sequence of epithelial and inflammatory changes in the distal airway. Inhalation Toxicol. 4, 17-31.
4. Bowen, R. M., Hoidal, J. R., and Estensen, R. D. (1985). Urokinase-type plasminogen activator in alveolar macrophages and bronchoalveolar lavage fluid from normal and smoke-exposed hamsters and humans. J. Lab. Clin. Med. 106, 667-673.
5. Daughaday, C. C., and Douglas, S. D. (1976). Membrane receptors on rabbit and human pulmonary alveolar macrophages. J. Reticuloendothel. Soc. 19, 37-45.
6. Devlin, R. B., McDonnell, W. F., Perez, R., Becker, S., House, D. E., and Koren, H. S. (1991). Prolonged exposure of humans to ambient levels of ozone causes cellular and biochemical changes in the lung. Am. Rev. Respir. Dis. 4, 72-81.
7. Devlin, R. B., McKinnon, K. P., Noah, T., Becker, S., and Koren, H. S. (1994). Ozone-induced release of cytokines and fibronectin by alveolar macrophages and airway epithelial cells. Am. J. Physiol. 10, L612-L619.
8. Devlin, R. B., McKinnon, K. P., Reed, W., Carter, J. D., and Quay, J. L. (1995). In vitro ozone exposure induces increased expression of mRNAs coding for IL-6 and α-chemokines, but not β-chemokines, in human airway epithelial cells. In Correlations between in Vitro and in Vivo Investigations in Inhalation Toxicology (U. Mohr, K. B. Adler, D. L. Dungworth, C. C. Harris, C. G. Plopper, and R. Saracci, Eds.), ILSI Press, in press.
9. Folinsbee, L. J., McDonnell, W. F., and Horstman, D. H. (1988). Pulmonary function and symptom responses after 6.6 hour exposure to 0.12 ppm ozone with moderate exercise. JAPCA 38, 28-35.
10. Glover, D. E., Hernsten, J. H., Crider, W. L., and Strong, A. A. (1981). Design and performance of a system to control concentrations of common gaseous air pollutants within environmental laboratories use for human exposure studies. J. Environ. Sci. Health 16, 501-522.
11. Golden, J. A., Nadal, J. A., and Boushey, H. A. (1978). Bronchial hyperirritability in healthy subjects after exposure to ozone. Am. Rev. Respir. Dis. 118, 287-294.
12. Hatch, G. E., Slade, R., Harris, L. P., McDonnell, W. F., Devlin, R. B., Koren, H. S., Costa, D. L. and McKee, J. (1994). Ozone dose and effect in humans and rats. Am. J. Respir. Crit. Care Med. 150, 676-683.
13. Hazbun, M. E., Hamilton, R., Holian, A., and Eschenbacher, W. L. (1993). Ozone-induced increases in substance P and 8-epi-prostaglandin F2 alpha in the airways of human subjects. Am. Rev. Respir. Dis. 9, 568-572.
14. Hazucha, M. J., Folinsbee, L. J., and Seal, E., Jr. (1992). Effects of steady-state and variable ozone concentration profiles on pulmonary function. Am. Rev. Respir. Dis. 146, 1487-1493.
15. Holtzman, M. J., Cunningham, J. H., Sheller, J. R., Irsigler, G. B., Nadel, J. A., and Boushey, H. A. (1979). Effect of ozone on bronchial reactivity in atopic and nonatopic subjects. Am. Rev. Respir. Dis. 120, 1059-1067.
16. Horstman, D. H., Folinsbee, L. J., Ives, P. J., Abdul-Salaam, S., and McDonnell, W. F. (1990). Ozone concentration and pulmonary response relationships for 6.6 hour exposures with five hours of moderate exercise to 0.08, 0.10, and 0.12 ppm. Am. Rev. Respir. Dis. 142, 1158-1163.
17. Koren, H. S., Devlin, R. B., Graham, D. E., Mann, R., McGee, M. P., Horstman, D. H., Kozumbo, W. J., Becker, S., House, D. E., McDonnell, W. F., and Bromberg, P. A. (1989). Ozone-induced inflammation in the lower airways of human subjects. Am. Rev. Respir. Dis. 139, 407-415.
18. Kulle, T. J., Sauder, L. R., Hebel, J. R., and Chatham, M. D. (1985). Ozone response relationships in healthy nonsmokers. Am. Rev. Respir. Dis. 132, 36-41.
19. Matthay, M. A., Eschenbacher, W. L., and Goetzl, E. J. (1984). Elevated concentrations of leukotriene D4 in pulmonary edema fluid of patients with adult respiratory distress syndrome. J. Clin. Immunol. 4, 479-483.
20. McDonnell, W. F., Horstman, D. H., Hazucha, M. J., Seal, E., Haak, E. D., Salaam, S. A., and House, D. E. (1983). Pulmonary effects of ozone exposure during exercise: Dose-response characteristics. J. Appl. Physiol. 54, 1345-1352.
21. McDonnell, W. F., Horstman, D. H., Abdul-Salaam, S., Raggio, L. J., and Green, J. A. (1987). The respiratory responses of subjects with allergic rhinitis to ozone exposure and their relationship to nonspecific airway reactivity. Toxicol. Ind. Health 3, 507-517.
22. McGee, M. P., Wallin, R., Wheeler, F. B., and Rothberger, H. (1989). Initiation of the extrinsic pathway of coagulation by human and rabbit alveolar macrophages: A kinetic study. Blood 74, 1583-1590.
23. McGee, M. P., Devlin, R. B., and Koren, H. S. (1990). Tissue Factor and Factor VII messenger RNAs in human alveolar macrophages: Effects of breathing ozone. Blood 75, 122-127.
24. McKee, D., et al. (1988). U.S. EPA Review of the National Ambient Air Quality Standards for Ozone: Preliminary Assessment of Scientific and Technical Information, Office of Air Quality Planning and Standards, draft staff paper. [For copies, contact D. McKee, U.S. EPA, OAQPS, MD12, Research Triangle Park, NC 27711; (919) 541-5271].
25. McKinnon, K. P., Madden, M. C., Noah, T. L., and Devlin, R. B. (1993). In vitro ozone exposure increases release of arachidonic acid products from a human bronchial epithelial cell line. Toxicol. Appl. Pharmacol. 118, 215-223.
26. Pino, M. V., Levin, J. R., Stovall, M. Y., and Hyde, D. M. (1992). Pulmonary inflammation and epithelial injury in response to acute ozone exposure in the rat. Toxicol. Appl. Pharmacol. 112, 64-72.
27. Rennard, S. I., Hunninghake, G. W., Bitterman, P. B., and Crystal, R. B. (1981). Production of fibronectin by human alveolar macrophages: mechanisms for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. Proc. Natl. Acad. Sci. USA 78, 7147-7151.
28. Reynolds, H. Y., Atkinson, J. P., Newball, H. H., and Frank, M. M. (1975). Receptors for immunoglobulin and complement on human alveolar macrophages. J. Immunol. 114, 1813-1819.
29. Rothberger, H., McGee, M. P., and Lee, T. K. (1984). Tissue factor activity: A marker of alveolar macrophage maturation in rabbits: Effects of granulomatous pneumonitis. J. Clin. Invest. 73, 1524.
30. Schelegle, E. S., Siefkin, A. D., and McDonald, R. J. (1991). Time course of ozone-induced neutrophilia in normal humans. Am. Rev. Respir. Dis. 142, 1353-1358.
31. Seltzer, J., Bigby, B. G., Stulborg, M., Holtzman, M. J., Nadel, J. A., Ueki, I. F., Leikauf, G. D., Goetzl, E. J., and Boushey, H. A. (1986). Ozone-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J. Appl. Physiol. 60, 1321-1326.
32. Sharon, N. (1984). Surface carbohydrates and surface lectins are recognition determinants in phagocytosis. Immunol. Today 5, 143-147.
33. Shurin, S. B., and Stossel, T. P. (1978). Complement (C3)-activated phagocytosis by lung macrophages. J. Immunol. 120, 1305-1312.
34. Smith, C., and Johnson, D. A. (1985). Human bronchial leukocyte proteinase inhibitor. Biochem. J. 225, 463-472.
35. Stimler, N P., Hugh, T. E., and Bloor, C. E. (1980). Pulmonary injury induced by C3a and C5a anaphylatoxins. Am. J. Pathol. 100, 327-348.
36. Strong, A. A. (1978). Description of the CLEANS Human Exposure System, Research Triangle Park, NC. U.S. Environmental Protection Agency (EPA-600/1-78-064).
37. Young, C., and Bhalla, D. K. (1992). Time course of permeability changes and PMN influx in rat trachea following ozone exposure. Fundam. Applied Toxicol. 18, 175-180.